Clinical Site

Dallas, Texas 75390-8575

2 studies enrolling now · 13 studies all time

What they study most

Acne Inversa, Age-Related Macular Degeneration, Age-related Macular Degeneration, Bipolar Depression, Diabetes Mellitus, Type 2, Fatty Liver, Nonalcoholic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Hypertriglyceridemia, Malignant Melanoma, NAFLD, Neovascular Age-related Macular Degeneration

Studies at this site

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease — Completed
• A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) — Running, not enrolling
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed